1-allyl-3-butyl-8-(n-acetyl-4-aminobenzyl)-xanthine

**1-Allyl–3-butyl–8-(N-acetyl–4–aminobenzyl)–xanthine** is a synthetic xanthine derivative. Xanthines are purine-based compounds structurally related to caffeine and theophylline and are known for their activity as phosphodiesterase inhibitors and adenosine receptor antagonists. This compound has been described in chemical databases as an experimental small molecule with potential therapeutic applications but is not approved for clinical use. Its precise mechanism of action or pharmacological profile in humans remains uncharacterized; however, by analogy to other xanthines, it may act on phosphodiesterases or adenosine receptors[2][5][7]. No clinical trials or approved indications have been reported.

Other names

N-[4-(1-Allyl-3-butyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-ylmethyl)phenyl]acetamideN-[4-(1-Allyl-3-butyl-2,6-dioxo-purin-8-yImethyl)-phenyl]-acetamide628279–02–7